Infliximab Combined with Enteral Nutrition for Managing Crohn’s Disease Complicated with Intestinal Fistulas

Table 3

Comparison of CDAI, SES-CD, and fistula healing before and after treatment in all cases.

Group	Treatment time	CDAI	SES-CD	Fistula healing (cases)
Conventional	Before treatment	309.9 ± 69.3	8.1 ± 2.0	0 (0%)
	14 weeks after treatment	246.8 ± 63.9	6.2 ± 1.2	3 (13.6%)
	30 weeks after treatment	178.6 ± 46.6	4.9 ± 0.8	6 (27.3%)
IFX	Before treatment	325.6 ± 70.8	8.6 ± 2.2	0 (0%)
	14 weeks after treatment	235.5 ± 62.8	3.5 ± 0.8	8 (40.0%)
	30 weeks after treatment	125.6 ± 42.5	1.6 ± 0.5	18 (90.0%)

Compared with that before treatment in the IFX treatment group: .
Compared with the IFX treatment group: .